Sancheti Clinic Now in PCMC: Expert Arthritis Treatment Under One Roof

Arthritis is a condition that causes inflammation and damage within a joint, leading to pain, stiffness, swelling, and reduced mobility. Treatment depends on the type and severity but may include physiotherapy, medications, lifestyle changes, weight management, joint injections, and, in advanced cases where conservative measures no longer provide relief, joint replacement surgery.

Sancheti Hospital’s Rheumatology and Arthritis Department in Pune provides this complete pathway for patients across Pimpri-Chinchwad, Nigdi, Wakad, Akurdi, and the wider region. This guide covers the key arthritis types, which symptoms warrant specialist review, and what evidence-based treatment looks like in practice.

What Is a Rheumatologist?

A rheumatologist is a physician specialising in the diagnosis and medical management of arthritis, autoimmune joint conditions, and connective tissue diseases. The distinction from an orthopaedic surgeon is frequently misunderstood and genuinely matters. An orthopaedic surgeon addresses the structural damage that end-stage arthritis eventually produces: a joint destroyed enough to require replacement, a tendon requiring repair. A rheumatologist manages the disease process producing that damage, ideally years before surgical intervention becomes necessary.

In inflammatory conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, this distinction is not trivial. Unchecked inflammatory arthritis produces irreversible joint erosion within two years of onset in a significant proportion of patients. A rheumatologist’s toolkit is fundamentally different: disease-modifying antirheumatic drugs, biological therapies, and targeted agents that modify the immune pathways driving destruction. Anyone looking for a rheumatologist near Pimpri-Chinchwad in Pune needs this specialist, not a pain management pathway that leaves the underlying disease unaddressed.

Who Is Affected By Arthritis

Arthritis in India spans a wider age range than most patients expect. Osteoarthritis is the most common form, affecting adults from their 50s onwards, particularly the knees, hips, and hands, driven by age, excess weight, and cumulative joint loading. Rheumatoid arthritis is less common but considerably more damaging in its untreated form, affecting a small portion of India’s adult population with significantly higher rates in women than in men.

Gout is rising in urban India, driven by dietary shifts and alcohol consumption patterns that increase serum uric acid over time. Inflammatory arthritis, which includes RA, psoriatic arthritis, and ankylosing spondylitis, is particularly relevant for working-age adults because, unlike osteoarthritis, it can begin in the 20s and 30s. A person in their 30s presenting with morning stiffness, symmetrical hand swelling, and unexplained fatigue is not experiencing overwork. They need a rheumatology assessment.

Types of Arthritis

The six conditions below represent the most common presentations in specialist rheumatology practice. Each has a distinct cause, affected population, and treatment pathway.

Symptoms That Warrant a Specialist Assessment

The most important clinical distinction in arthritis is between inflammatory and mechanical joint pain, because the treatment pathway differs completely. Inflammatory arthritis produces symptoms that worsen with rest and improve with movement. Mechanical arthritis worsens with loading and improves with rest. If any of the following patterns are present for more than six weeks, a rheumatology assessment is appropriate rather than continued self-management.

• Morning stiffness lasting over 60 minutes that loosens as the day progresses: the defining feature of inflammatory arthritis.
• Symmetrical swelling in the small joints of both hands or wrists, particularly in women aged 30-55.
• Sudden severe pain, heat, and swelling in a single joint, especially after a rich meal or alcohol: possible gout attack.
• Low back pain that is worst in the mornings, improves with exercise, and does not improve with lying down: possible ankylosing spondylitis.
• Joint pain occurring alongside psoriasis, nail pitting, or skin rashes: possible psoriatic arthritis.

How Arthritis Is Diagnosed

Accurate arthritis diagnosis requires the rheumatologist to correlate clinical findings with blood results and imaging. No single test confirms an arthritis type in isolation. The combination is what determines the diagnosis and, crucially, the specific treatment pathway. Patients who arrive with an MRI report and no clinical assessment are frequently over-diagnosed or under-diagnosed as a result.

• Blood tests: Rheumatoid factor (RF) and anti-CCP antibodies for RA; ESR and CRP for systemic inflammation; serum uric acid for gout; HLA-B27 for ankylosing spondylitis
• Imaging: X-ray for joint space narrowing and erosion; musculoskeletal ultrasound for early synovitis not yet visible on X-ray; MRI for sacroiliac joint assessment in ankylosing spondylitis
• Joint fluid analysis: Microscopy to identify uric acid or calcium pyrophosphate crystals; essential for confirming gout and distinguishing it from septic arthritis
• Disease activity scoring: The DAS28 score quantifies RA activity at each review visit and directly guides escalation decisions

Treatment of Arthritis

The fundamental shift in arthritis treatment over the past two decades is from symptom control to disease modification. The goal is no longer simply managing pain; it is achieving sustained remission or low disease activity and preventing joint damage from accumulating. This treat-to-target approach, which underpins the 2025 EULAR guidelines, requires DMARDs to be started immediately at diagnosis, with the treatment escalated if the remission target is not met within three to six months.

• Conventional DMARDs: Methotrexate is the established first-line agent for RA; leflunomide or sulfasalazine are used when methotrexate is contraindicated
• Biologics and JAK inhibitors: TNF inhibitors (adalimumab, etanercept), IL-6 inhibitors (tocilizumab), and JAK inhibitors (baricitinib, tofacitinib) for patients not reaching target on conventional DMARDs
• Gout: Colchicine or NSAIDs for the acute attack; allopurinol for long-term urate lowering once the attack fully resolves
• Osteoarthritis: Weight reduction, exercise, and injections first; joint replacement for end-stage structural failure
• Rehabilitation: A physiotherapist provides joint protection techniques, targeted strengthening, and functional training alongside every drug programme

Why Early Arthritis Treatment in PCMC Matters

The biggest mistake many patients make is assuming joint pain is a normal part of ageing and waiting until symptoms become severe before seeking specialist care. While this may be reasonable for mild mechanical osteoarthritis, inflammatory arthritis behaves very differently. Ongoing inflammation can permanently damage cartilage, bone, tendons, and ligaments long before visible deformity develops. 

Early diagnosis allows treatment to begin during the period when joint damage is still preventable, improving the likelihood of achieving remission and preserving long-term function. Even in osteoarthritis, timely intervention with weight management, physiotherapy, activity modification, and targeted medications can reduce pain, slow functional decline, and delay or even avoid the need for joint replacement. Whether symptoms are caused by rheumatoid arthritis, gout, ankylosing spondylitis, or osteoarthritis, seeking specialist assessment early provides the best opportunity to protect joint health, maintain mobility, and preserve independence for years to come.

Recovery and Disease Monitoring

Arthritis management is a long-term partnership between patient and specialist. The monitoring schedule below reflects standard practice for inflammatory arthritis; frequency adjusts based on disease activity.

Prevention and Long-Term Management

Prevention in arthritis takes two forms: reducing factors that accelerate joint damage, and ensuring established disease does not progress faster than it needs to. Several of the most important levers are directly in the patient’s control.

• Osteoarthritis: Sustained weight management reduces knee joint loading by approximately four kilograms for every kilogram of body weight lost; resistance exercise preserves muscle that protects the joint cartilage.
• Rheumatoid arthritis: Strict medication adherence is the single most effective intervention; smoking is the strongest environmental trigger for RA and cessation reduces flare frequency significantly.
• Gout: Limiting red meat, organ meats, fructose, and alcohol; maintaining adequate hydration; sustaining uric acid below 360 micromol/L on long-term allopurinol therapy.
• General principle: Joint pain with morning stiffness or systemic features lasting more than six weeks warrants specialist referral, not indefinite self-management.

Key Takeaways

• Arthritis is not a single condition. Osteoarthritis, rheumatoid arthritis, gout, ankylosing spondylitis, and psoriatic arthritis each have different causes, affected populations, and treatment pathways.
• Most patients searching for an arthritis doctor in PCMC have been managing symptoms rather than treating the underlying disease. The gap between pain control and disease modification is where irreversible joint damage accumulates.
• Morning stiffness lasting over 60 minutes, symmetrical small joint swelling, or systemic fatigue with joint pain in a person under 60 indicates inflammatory arthritis and warrants prompt rheumatology referral.
• Treat-to-target means aiming for remission or low disease activity, confirmed by DAS28 scoring at every review, not simply a reduction in pain. DMARD therapy begins at diagnosis, not after waiting to see how disease evolves.
• Biologics and JAK inhibitors available in India provide effective disease control for patients who do not reach target on conventional DMARDs. These therapies require monitoring but carry manageable risk profiles.
• Patients looking for a joint pain specialist in Pimpri can access the full arthritis care pathway at Sancheti Hospital, Pune: specialist diagnosis, DMARD and biologic therapy, and coordinated rehabilitation in one centre.

Frequently Asked Questions (FAQs)

Q1. My joints hurt in the morning but improve by afternoon. Is this arthritis?

Morning stiffness that resolves within 30 minutes is typical of osteoarthritis, where overnight joint rest causes temporary gelling. Stiffness lasting over 60 minutes that eases with movement rather than rest is a hallmark of inflammatory arthritis, including rheumatoid arthritis. If you have had this pattern for more than six weeks alongside joint swelling or unusual fatigue, a rheumatologist assessment with baseline blood tests is appropriate rather than continuing with anti-inflammatory pain relief alone. Duration of morning stiffness is one of the most useful clinical discriminators between inflammatory and mechanical joint disease.

Q2. Is rheumatoid arthritis curable?

RA is not curable in the traditional sense, but it is highly controllable with modern treatment. With the treat-to-target approach using DMARDs and, where needed, biologics, the majority of patients today achieve sustained remission: no active joint inflammation, no progression of joint erosion on imaging, and near-normal daily function. The important clinical point is that this outcome requires treatment to be started early and adjusted proactively when the disease activity target is not being met. Remission achieved and maintained long-term is functionally indistinguishable from cure in terms of quality of life and joint preservation.

Q3. I have high uric acid on my blood test. Do I have gout?

Elevated serum uric acid alone is not gout. Gout is a clinical diagnosis: it requires an acute attack of sudden severe pain, heat, and swelling in a joint, confirmed either clinically or by identifying uric acid crystals on joint fluid microscopy. Many people with persistently high uric acid never develop gout. However, consistently elevated levels above 480 micromol/L do significantly increase the risk of crystal deposition over time. If you have already had a confirmed gout attack, long-term urate-lowering therapy with allopurinol prevents recurrence and protects joint and kidney health from progressive uric acid deposition.

Q4. When should I see a rheumatologist rather than an orthopaedic surgeon?

An orthopaedic surgeon is the right specialist when a joint has been damaged to the point where a structural procedure is the solution: a joint replacement for destroyed cartilage, fixation for a fracture, or a ligament repair. A rheumatologist is the right first specialist when the underlying disease process needs to be identified and modified: when you have swollen, inflamed joints rather than worn ones; when multiple joints are involved; or when systemic features like fatigue, weight loss, or skin changes accompany joint pain. Seeing a rheumatologist early, before structural damage is established, is the correct sequence for any suspected inflammatory joint disease.

Q5. Are biologic injections safe for long-term use?

Biologics have more than two decades of real-world safety data in rheumatology and are considered appropriate for long-term use in correctly selected patients. The main monitoring requirement is regular tuberculosis screening before starting and at intervals during treatment, given India’s TB burden, alongside monitoring for infection risk and, with JAK inhibitors, cardiovascular factors. Patients on biologics require three- to six-monthly specialist reviews. The clinical consensus is clear: the risks of well-monitored biologic therapy are substantially lower than the cumulative risks of undertreated inflammatory arthritis, which include progressive joint destruction, cardiovascular disease from sustained systemic inflammation, and significant long-term disability.